[Federal Register Volume 63, Number 18 (Wednesday, January 28, 1998)]
[Notices]
[Page 4269]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-1998]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee on Immunization Practices: Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Advisory Committee on Immunization Practices (ACIP).
    Times and Dates: 8:30 a.m.-5:15 p.m., February 11, 1998; 8:30 
a.m.-1:15 p.m., February 12, 1998.
    Place: CDC, Auditorium B, Building 2, 1600 Clifton Road, NE, 
Atlanta, Georgia 30333.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee is charged with advising the Director, 
CDC, on the appropriate uses of immunizing agents. In addition, 
under 42 U.S.C. 1396s, the Committee is mandated to establish and 
periodically review and, as appropriate, revise the list of vaccines 
for administration to vaccine-eligible children through the Vaccines 
for Children (VFC) program, along with schedules regarding the 
appropriate periodicity, dosage, and contraindications applicable to 
the vaccines.
    Matters To Be Discussed: Agenda items will include updates from 
the National Center for Infectious Diseases; the National 
Immunization Program; the Vaccine Injury Compensation Program; the 
National Vaccine Program; update on influenza A(H5N1): epidemiologic 
and virologic surveillance and present status of vaccine 
development; update on influenza surveillance--U.S. and worldwide; 
influenza vaccination and Guillain Barre syndrome: update and 
proposed changes to ACIP recommendations; proposed changes to the 
1998-1999 ACIP recommendations for prevention and control of 
influenza; immunization of bone marrow transplant recipients 
recommendations on the use of Rotashield (rotavirus 
vaccine) as part of the routine childhood immunization schedule; 
report of work group on computerization of ACIP recommendations; 
ACIP combination vaccines recommendation; comprehensive resolutions 
for the Vaccines for Children (VFC) Program; vaccine identification 
standards initiative; and alopecia associated with hepatitis B 
vaccination. Other matters of relevance among the committee's 
objectives may be discussed.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Gloria A. Kovach, Committee 
Management Specialist, CDC, 1600 Clifton Road, NE, M/S D-50, 
Atlanta, Georgia 30333, telephone 404/639-7250.

    Dated: January 21, 1998.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 98-1998 Filed 1-27-98; 8:45 am]
BILLING CODE 4163-18-P